The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing antibody drug conjugates and therapeut

Total Raised

$120 M

Rounds

1

Links

Verticals

Biopharma
Biotechnology
Health Care
Therapeutics

Investment History

  1. Equity

    Nov 2025

    $120M

Team

Dave Johnson

CEO and Founder

Langdon L Miller, MD

Executive Vice President of Development and Chief Medical Officer

Elyse Greenberg, Ph.D.

Program and Project Management

Nicole Miller

Senior Scientist